Achelois Pharmaceuticals Overview
- Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Achelois Pharmaceuticals General Information
Description
Developer of nontoxic therapeutics based in San Francisco, California. The company develops technologies to reprogram T cells and turn T cell medicine into powerful medicine for solid tumors, enabling patients to inhibit tumors and eliminate pain caused by cancer.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
+1 (650) 000-0000
Achelois Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Achelois Pharmaceuticals Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Chang-Zheng Chen Ph.D | Founder & Chief Executive Officer |
Achelois Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| QB3 | Accelerator/Incubator | 000 0000 | 000000 0 |